This study aims to discover the immunomodulatory potential of the ethanol extract (EE) and the ethyl acetate fraction (EAF) of Curcuma heyneana Valeton and Zijp (Indonesian name: temu giring) rhizome using mice models. The affinity of the curcuminoid (curcumin, dimethoxy-, and bisdemethoxy-) through the Transient Receptor Potential Vanilloid 1 (TRPV1) was determined using Mollegro molecular docking in silico. The curcuminoid concentration of the EE and EAF of C. heyneana rhizome were determined using thin-layer chromatography densitometry. In vivo studies in mice models were conducted using the carbon clearance method to determine the phagocytosis index, and the number of leukocytes in the blood and spleen. Forty mice were divided into eight groups, including negative control (given 1% CMC-Na), positive control (given Stimuno Forte® suspension at a dose of 6.5 mg/kg BW), three groups given the EAF of C. heyneana rhizome extract at a dose of 125 mg/kg BW, 250 mg/kg BW, and 500 mg/kg BW, respectively, and three groups were given EE of temu giring rhizome extract with doses of 125 mg/kg BW, 250 mg/kg BW, and 500 mg/kg BW, respectively. E.E. and E.A.F. of C. heyneana (temu giring) rhizome extract contained dimethoxy curcumin (0.176 ± 0.01 and 4.53 ± 0.02 %b/b) greater than another curcuminoid, bisdemetoxy curcumin and curcumin. EE at 125 mg/kg BW and EAF dose at 500 mg/kg B W. of temu giring rhizome have immunostimulant activity with a phagocytosis index value of >1 compared to the negative control (p < 0.05). Additionally, both increase the number of lymphocytes, monocytes, and neutrophil cells in peripheral blood and spleen compared to the negative control (p < 0.05). Their activity was seen as similar to the positive control. Therefore, the EE of C. heyneana rhizome has immunostimulant activity, and the EAF of C. heyneana rhizome has immunosuppressant activity at 125 mg/kg BW and immunostimulant at a higher dose. The activity of temu giring as an immunomodulator was associataed with its affinity to TRPV1.
5 January 2022 in Indonesian Journal of Pharmaceutical Science and Technology
Red ginger contains 6-shogaol, which has a neuroprotective effect and is crucial in several brain diseases, including Alzheimer’s. This study investigated the neuroprotective effect of red ginger extract (RGE) containing 6-shogaol on scopolamine-induced memory loss in mice. Male Balb/C mice (n = 30; 6–7 weeks old) were divided into six groups: normal, Alzheimer, drug control (donepezil), and RGE (100, 200, and 400 mg/kg BW). In the acute experiment, the mice were treated 60 minutes before the test, followed by 1 mg/kg of scopolamine 30 minutes later. Thirty minutes later, the mice were placed individually in a Y-maze to observe spontaneous alteration activity (SAA). In the chronic experiment, the mice were treated once daily for seven days. On days 8–14, the mice were administered scopolamine and treatment. SAA was observed every 3–4 days. On day 15, malondialdehyde (MDA) and acetylcholinesterase (AChE) levels in the serum and brain were determined. RGE treatment 400 mg/kg BW, containing 1.664 µg of 6-shogaol per 100 mg of ethanol RGE, reduced memory loss better than the other two doses. RGE successfully decreased MDA and increased AChE in the serum and brain. RGE also showed effectively to improve memory in Alzheimer’s disease.
• To our knowledge, this study is the first report of the potency of ethanolic extract from cocoa pod husk (EECPH) in neuropathy diabetes. In our finding, the EECPH dose of 750 mg/kg BW could reduce the blood glucose levels as well as hyperalgesia in alloxan-induced diabetic neuropathy mice. Other biochemical parameters also showed positive changes such as MDA levels, total cholesterol, SGOT, and SGPT. The EECPH dose of 750 mg/kg BW also improved the histology of the pancreas and spinal cords. The expression of TRPV1 in the pancreas and spinal cords were opposite and defined that TRPV1 might responsible for hyperalgesia and insulin secretion in DN mice.
31 May 2025 in Tropical Journal of Natural Product Research
Phenolic compounds found in cocoa pod husk have the potential to inhibit pro-inflammatory immune responses, indicating their ability to reduce pain. Therefore, this study aims to evaluate the analgesic and anti-inflammatory properties of ethanol extract of cocoa pod husk (EECPH). Protein denaturation, membrane stability, and antiproteinase were used to evaluate the anti-inflammatory properties of cocoa pod husk, which was extracted using 96% ethanol. In vivo tests for analgesic and anti-inflammatory effects were carried out using formalin and Complete Freund’s Adjuvant (CFA). EECPH was administered to mice at dosages of 250, 500, and 750 mg/kg body weight (BW), with diclofenac sodium serving as the positive control. The results indicated that the inhibitory activity of protein denaturation from EECPH (IC50 16.542 ± 3.095 μg/mL) was comparable to diclofenac sodium. However, the proteinase inhibitory activity (IC50 100.691 ± 7.663 μg/mL) was lower compared to diclofenac sodium. In the membrane stabilization test using heat induction, the activity of EECPH (IC50 74.78 ± 5.53 μg/mL) was also lower than diclofenac sodium. Meanwhile, the hypotonicity test revealed that the IC50 (6.24 ± 0.37 μg/mL) was similar to diclofenac sodium. The results also showed that EECPH was effective in reducing pain and inflammation in mice. At a dosage of 500 mg/kg, it decreased the total leukocyte count and the percentages of neutrophils and lymphocytes in mice after CFA treatment. In conclusion, the ethanol extract of cocoa pod husk exhibited significant analgesic and anti-inflammatory properties by preventing protein denaturation, stabilizing cell membranes, and reducing proteinase activity.